IL287979A
(en )
2022-01-01
Dosage regimes for the administration of a lag-3/pd-l1 bispecific antibody
EP3916016A4
(en )
2022-11-02
Novel bispecific antibody molecule and bispecific antibody simultaneously combining pd-l1 and lag-3
EP3784214A4
(en )
2022-01-19
Liquid oral pharmaceutical dosage form
EP4098277A4
(en )
2024-01-31
Stable anti-pd-1 antibody pharmaceutical preparation
EP3768727A4
(en )
2021-12-22
Novel bispecific pd-1/lag-3 antibody molecules
EP3833691A4
(en )
2022-05-18
Human pd-l1 antibodies
HK40071349A
(en )
2022-11-04
Dosage regimes for the administration of a lag-3/pd-l1 bispecific antibody
EP3647323A4
(en )
2021-10-27
Anti-gitr antibody, antigen-binding fragment thereof, and pharmaceutical use thereof
IL281398A
(en )
2021-04-29
Process for the preparation of a coated solid pharmaceutical dosage form
AU2020356348B2
(en )
2025-07-24
Pharmaceutical compounds
EP3980034A4
(en )
2024-02-28
T-cell depleting therapies
GB201914040D0
(en )
2019-11-13
Dosage regimes for the administration of lag-3/pd-l1 bispecific antibody
GB202000318D0
(en )
2020-02-26
Dosage regimes for the administration of LAG-3/PD-L1 bispecific antibody
GB201906807D0
(en )
2019-06-26
Dosages regimes for the administration of lag-3/pd-l1 bispectic antibody
EP4055061A4
(en )
2023-12-20
Dosage regimen for anti-egfrviii agents
HK40066344A
(en )
2022-08-12
Ox40/pd-l1 bispecific antibody
HK40066344B
(en )
2024-10-04
Ox40/pd-l1 bispecific antibody
HK40049719A
(en )
2021-12-17
Dosing regimen for the treatment of pi3k related disorders
HK40113969A
(en )
2025-02-28
Dosage regimes for the administration of glucagon-like-peptide-2 (glp-2) analogues
HK40108365A
(en )
2024-11-08
Pharmaceutical composition comprising anti-pvrig/tigit bispecific antibody
HK40074182A
(en )
2022-12-30
Dosing regimen for anti-dll3 agents
HK40115214A
(en )
2025-03-28
Dosing for treatment with anti-tigit and anti-pd-l1 antagonist antibodies
HK40076627A
(en )
2023-02-17
Gel-chewable dosage form
HK40059540A
(en )
2022-05-06
Pharmaceutical compositions comprising bispecific anti-cd37 antibodies
TWI900489B
(en )
2025-10-11
Pharmaceutical compounds